Skip to main content
Frontiers in Psychiatry logoLink to Frontiers in Psychiatry
. 2026 Sep 4;17:1972400. doi: 10.3389/fpsyt.2026.1972400

Correction: Comparative efficacy and safety of seven Chinese patent medicines combined with SSRIs for depressive disorder: a systematic review and network meta-analysis

Hongye Geng 1,†, Lixuan Li 1,†, Chengyuan Lu 1, Shuling Wang 1,*
PMCID: PMC13588201  PMID: 42761930

There was a mistake in Table 1 as published. The original table did not clearly display the comparator group “SSRIs monotherapy” and omitted the corresponding mean differences (95% CI) for comparisons with certain interventions. To improve readability and facilitate correct interpretation of the network meta-analysis, the corrected Table 1 now presents all interventions in a clear, side-by-side format against SSRIs monotherapy as the common reference. All numerical values remain unchanged from the original analysis; this correction does not affect the study's findings or conclusions. The corrected Table 1 appears below.

Table 1.

League table for HAMD improvement (MD, 95% CI).

BJTGT+SSRIs
-1.42
[-5.11, 2.27]
JYW+SSRIs
0.03
[-3.15, 3.21]
1.45
[-0.95, 3.85]
SGJY+SSRIs
3.58
[0.58, 6.58]
4.99
[2.84, 7.15]
3.55
[2.49, 4.61]
SSRIs
1.46
[-2.68, 5.60]
2.88
[-0.70, 6.45]
1.43
[-1.62, 4.47]
-2.12
[-4.97, 0.73]
TM+SSRIs
1.12
[-2.83, 5.08]
2.54
[-0.82, 5.90]
1.10
[-1.69, 3.88]
-2.45
[-5.03, 0.13]
-0.33
[-4.18, 3.51]
WL+SSRIs
0.92
[-2.60, 4.44]
2.34
[-0.49, 5.17]
0.89
[-1.23, 3.02]
-2.65
[-4.49, -0.82]
-0.54
[-3.93, 2.86]
-0.20
[-3.37, 2.96]
XYW+SSRIs
1.68
[-4.76, 8.11]
3.09
[-2.99, 9.18]
1.65
[-4.14, 7.44]
-1.90
[-7.59, 3.79]
0.22
[-6.15, 6.58]
0.55
[-5.70, 6.80]
0.75
[-5.23, 6.73]
YXQN+SSRIs

Values in the upper-right triangle represent mean differences versus SSRIs monotherapy; values in the lower-left triangle represent pairwise comparisons between CPM+SSRI combinations. Negative values favor the column intervention.

Bold values indicate 95% CI does not include 0.

The original version of this article has been updated.

Footnotes

Edited and reviewed by: Andrea Fiorillo, University of Campania Luigi Vanvitelli, Italy

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Psychiatry are provided here courtesy of Frontiers Media SA

RESOURCES